{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:02Z","timestamp":1786991882261,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["82104072"],"award-info":[{"award-number":["82104072"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010896"],"award-info":[{"award-number":["2024A1515010896"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.022","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:17:49Z","timestamp":1718327869000},"page":"43-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Targeted treatment for biofilm-based infections using PEGylated tobramycin"],"prefix":"10.1016","volume":"372","author":[{"given":"Li","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafi Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.022_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the United States during the 20th century","volume":"281","author":"Armstrong","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00148581-200709001-00004","article-title":"A formulation of aerosolized tobramycin (Bramitob\u00ae) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection","volume":"9","author":"Chuchalin","year":"2007","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0015","first-page":"179","article-title":"Tobramycin administered by the TOBI\u00ae Podhaler\u00ae for persons with cystic fibrosis: a review","volume":"4","author":"VanDevanter","year":"2011","journal-title":"Med. Devi. (Auckland, NZ)"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0020","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ppul.22989","article-title":"Long-term efficacy and safety of aerosolized tobramycin 300 mg\/4 ml in cystic fibrosis","volume":"49","author":"Mazurek","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120768","article-title":"Pulmonary biofilm-based chronic infections and inhaled treatment strategies","volume":"604","author":"Ding","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0030","article-title":"Antibiotic resistance: a\u201c dark side\u201d of biofilm-associated chronic infections, Polskie Archiwum Medycyny Wewn\u0119trznej= polish","volume":"123","author":"Marcinkiewicz","year":"2013","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apm.12099","article-title":"The role of bacterial biofilms in chronic infections","volume":"121","author":"Bjarnsholt","year":"2013","journal-title":"Apmis"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2006.12.029","article-title":"Biofilms and their relevance to veterinary medicine","volume":"121","author":"Clutterbuck","year":"2007","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0050","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JB.00858-07","article-title":"The EPS matrix: the \u201chouse of biofilm cells\u201d","volume":"189","author":"Flemming","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00203-014-0983-1","article-title":"Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments","volume":"196","author":"Abdallah","year":"2014","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0065","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0070","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1517\/17425255.2014.967679","article-title":"Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns","volume":"10","author":"Zhang","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.08.017","article-title":"Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG","volume":"311","author":"McSweeney","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0085","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1002\/ange.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"120","author":"Wang","year":"2008","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120215","article-title":"Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery","volume":"596","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0095","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1039\/c0ob01133a","article-title":"Assessment of 6\u2032-and 6\u2032\u2032\u2032-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance","volume":"9","author":"Shaul","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0100","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.molpharmaceut.8b00011","article-title":"PEGylation of tobramycin improves mucus penetration and antimicrobial activity against Pseudomonas aeruginosa biofilms in vitro","volume":"15","author":"Bahamondez-Canas","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0105","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/mp500846u","article-title":"Improved biofilm antimicrobial activity of polyethylene glycol conjugated tobramycin compared to tobramycin in pseudomonas aeruginosa biofilms","volume":"12","author":"Du","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0110","unstructured":"Preparation Mmethod of Mmonomethyl Ppolyethylene Gglycol Ccarboxylic Aacid and Aapplication Tthereof, https:\/\/patents.google.com\/patent\/CN104877124A\/en?oq=CN104877124, Hunan Huateng Pharmaceutical Co Ltd, China, 2015."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0115","series-title":"Bioconjugate Techniques","author":"Hermanson","year":"2013"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-anchem-071114-040315","article-title":"Ionization mechanism of matrix-assisted laser desorption\/ionization","volume":"8","author":"Lu","year":"2015","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0125","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s13361-016-1495-9","article-title":"Quantification of carbohydrates and related materials using sodium ion adducts produced by matrix-assisted laser desorption ionization","volume":"27","author":"Ahn","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0130","first-page":"197","article-title":"Assay development for aminoglycosides by HPLC with direct UV detection","volume":"55","author":"Blanchaert","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0135","series-title":"Chemical Biology","first-page":"243","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2015"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0145","first-page":"1","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chemother."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0150","series-title":"D. Studio, Version 2.5","year":"2009"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","article-title":"Making optimal use of empirical energy functions: force-field parameterization in crystal space","volume":"57","author":"Krieger","year":"2004","journal-title":"Proteins: Struct. Funct. Bioinformat."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ja.2011.72","article-title":"Structural characterization of the tobramycin\u2013piperacillin reaction product formed at pH 6.0","volume":"64","author":"Pagano","year":"2011","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0165","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1021\/ja00438a020","article-title":"Nitrogen-15 nuclear magnetic resonance spectroscopy. The nebramycin aminoglycosides","volume":"98","author":"Dorman","year":"1976","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0170","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1128\/JB.181.22.6977-6986.1999","article-title":"A novel lipolytic enzyme located in the outer membrane of Pseudomonas aeruginosa","volume":"181","author":"Wilhelm","year":"1999","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0175","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1128\/JB.00023-07","article-title":"The autotransporter esterase EstA of Pseudomonas aeruginosa is required for rhamnolipid production, cell motility, and biofilm formation","volume":"189","author":"Wilhelm","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0180","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects P seudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0185","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.mib.2007.09.010","article-title":"Role of polysaccharides in Pseudomonas aeruginosa biofilm development","volume":"10","author":"Ryder","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0190","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1099\/13500872-145-6-1349","article-title":"Mucoid conversion of Pseudomonas aeruginos by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung","volume":"145","author":"Mathee","year":"1999","journal-title":"Microbiology"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2014.11.022","article-title":"Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase)","volume":"198","author":"Deacon","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-018-0056-3","article-title":"Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides","volume":"4","author":"Powell","year":"2018","journal-title":"NPJ Biofilms Microbiom."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0205","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.jmb.2015.09.002","article-title":"The limitations of in vitro experimentation in understanding biofilms and chronic infection","volume":"427","author":"Roberts","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41522-018-0047-4","article-title":"Tools for studying growth patterns and chemical dynamics of aggregated Pseudomonas aeruginosa exposed to different electron acceptors in an alginate bead model","volume":"4","author":"S\u00f8nderholm","year":"2018","journal-title":"NPJ Biofilms Microbiom."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijbiomac.2020.01.217","article-title":"Alginate-poloxamer beads for clotrimazole delivery: molecular interactions, mechanical properties, and anticandidal activity","volume":"148","author":"Khlibsuwan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2023.11.032","article-title":"Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment","volume":"365","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0225","series-title":"Tobramycin Administered by the TOBI\u00ae Podhaler\u00ae for Persons with Cystic Fibrosis: A Review","first-page":"179","author":"VanDevanter","year":"2011"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/41.3.329","article-title":"The role of TNF-\u03b1 in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA\/SCID mouse chimera","volume":"41","author":"Matsuno","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s15010-005-4096-2","article-title":"Diagnostic and prognostic values of admission procalcitonin levels in community\u2013acquired pneumonia in an intensive care unit","volume":"33","author":"Boussekey","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122011","article-title":"Co-spray-dried poly-L-lysine with L-leucine as dry powder inhalations for the treatment of pulmonary infection: moisture-resistance and desirable aerosolization performance","volume":"624","author":"Zhang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0250","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.scib.2023.11.004","article-title":"Polymyxin B sulfate inhalable microparticles with high-lectin-affinity sugar carriers for efficient treatment of biofilm-associated pulmonary infections","volume":"68","author":"Zhou","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0255","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/biot.201200325","article-title":"PEG chain length impacts yield of solid-phase protein PEGylation and efficiency of PEGylated protein separation by ion-exchange chromatography: insights of mechanistic models","volume":"8","author":"Yoshimoto","year":"2013","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0265","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1021\/acschembio.6b00349","article-title":"Conjugation strategy strongly impacts the conformational stability of a PEG-protein conjugate","volume":"11","author":"Lawrence","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.memsci.2013.03.003","article-title":"Increase in hydrophilicity of polysulfone membrane using polyethylene glycol methyl ether","volume":"437","author":"Sinha","year":"2013","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0275","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1099\/jmm.0.45539-0","article-title":"Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation","volume":"53","author":"Stapper","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0280","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/jac\/dkv058","article-title":"Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model","volume":"70","author":"Cao","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2024.06.022_bb0285","article-title":"Diffusion retardation by binding of tobramycin in an alginate biofilm model","volume":"11","author":"Cao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0290","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cyto.2018.12.009","article-title":"Tea polyphenols protect gingival keratinocytes against TNF-\u03b1-induced tight junction barrier dysfunction and attenuate the inflammatory response of monocytes\/macrophages","volume":"115","author":"Lagha","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2024.06.022_bb0295","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.biopha.2017.11.149","article-title":"Procalcitonin: the marker of pediatric bacterial infection","volume":"96","author":"Memar","year":"2017","journal-title":"Biomed. Pharmacother."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:34:12Z","timestamp":1750102452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"alternative-id":["S0168365924003705"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted treatment for biofilm-based infections using PEGylated tobramycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}